Goodlet Kellie J, McCreary Erin K, Nailor Michael D, Barnes Darina, Brokhof Marissa M, Bova Sarah, Clemens Evan, Kelly Beth, Lichvar Alicia, Pluckrose Dawn M, Summers Bryant B, Szempruch Kristen R, Tchen Stephanie
Department of Pharmacy Practice, Midwestern University, Glendale, Arizona, USA.
Department of Medicine, Division of Infectious Diseases, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Open Forum Infect Dis. 2024 Jun 15;11(7):ofae342. doi: 10.1093/ofid/ofae342. eCollection 2024 Jul.
Infection management in solid organ transplantation poses unique challenges, with a diverse array of potential pathogens and associated antimicrobial therapies. With limited high-quality randomized clinical trials to direct optimal care, therapeutic "myths" may propagate and contribute to suboptimal or excessive antimicrobial use. We discuss 6 therapeutic myths with particular relevance to solid organ transplantation and provide recommendations for infectious diseases clinicians involved in the care of this high-risk population.
实体器官移植中的感染管理面临着独特的挑战,存在各种各样的潜在病原体及相关抗菌治疗方法。由于指导最佳治疗的高质量随机临床试验有限,治疗“误区”可能会传播,并导致抗菌药物使用不当或过度。我们讨论了与实体器官移植特别相关的6个治疗误区,并为参与护理这一高危人群的传染病临床医生提供建议。